Cigna Group $CI Shares Bought by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership raised its holdings in Cigna Group (NYSE:CI) by 9.8% during the fourth quarter, HoldingsChannel.com reports. The firm owned 2,958,656 shares of the health services provider’s stock after buying an additional 263,036 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Cigna Group were worth $814,311,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Aptus Capital Advisors LLC increased its holdings in shares of Cigna Group by 12.1% in the 4th quarter. Aptus Capital Advisors LLC now owns 5,480 shares of the health services provider’s stock valued at $1,508,000 after acquiring an additional 591 shares during the last quarter. FORA Capital LLC increased its holdings in shares of Cigna Group by 499.8% in the 4th quarter. FORA Capital LLC now owns 21,154 shares of the health services provider’s stock valued at $5,800,000 after acquiring an additional 17,627 shares during the last quarter. CreativeOne Wealth LLC increased its holdings in shares of Cigna Group by 6.5% in the 4th quarter. CreativeOne Wealth LLC now owns 1,648 shares of the health services provider’s stock valued at $454,000 after acquiring an additional 100 shares during the last quarter. Kestra Advisory Services LLC increased its holdings in shares of Cigna Group by 4.7% in the 4th quarter. Kestra Advisory Services LLC now owns 15,831 shares of the health services provider’s stock valued at $4,357,000 after acquiring an additional 716 shares during the last quarter. Finally, Transamerica Financial Advisors LLC increased its holdings in shares of Cigna Group by 6.4% in the 4th quarter. Transamerica Financial Advisors LLC now owns 2,459 shares of the health services provider’s stock valued at $677,000 after acquiring an additional 148 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on CI shares. Raymond James Financial set a $340.00 price target on Cigna Group in a report on Friday, May 1st. Sanford C. Bernstein boosted their price target on Cigna Group from $358.00 to $371.00 and gave the company an “outperform” rating in a report on Tuesday, May 5th. Wells Fargo & Company upped their price objective on Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research note on Friday, May 1st. Guggenheim upped their price objective on Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Finally, Piper Sandler lowered their price objective on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research note on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $338.80.

Cigna Group Price Performance

Shares of CI opened at $297.77 on Friday. The company has a market cap of $78.77 billion, a P/E ratio of 12.62, a PEG ratio of 1.15 and a beta of 0.28. The stock has a fifty day moving average price of $282.53 and a 200 day moving average price of $278.01. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. Cigna Group has a 12 month low of $239.51 and a 12 month high of $338.89.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The firm had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm’s revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the business earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts forecast that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is presently 26.45%.

Insider Activity

In other news, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.